In addition to Cores directly supported by DRTC, investigators may find the following resources — both internal and external — particularly useful for their research programs.


The Vanderbilt Diabetes Center is supported by funding from the NIH (P30 DK20593).


islet man logo  

Vanderbilt Diabetes Day

Director: Sean Davies, PhD and Sarah Jaser, PhD

A DRTC-sponsored annual conference bringing together diabetes researchers and trainees. 


Vanderbilt Mouse Metabolic Phenotyping Center (MMPC)

Director: David Wasserman, PhD

The MMPC advances research by providing novel experimental tools to the scientific community for phenotyping genetic mouse models related to diabetes, obesity, and other metabolic diseases.

DRCs logo  

NIDDK Diabetes Research Centers

NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. The Diabetes Research Centers (DRCs) promote new discoveries and enhance scientific progress through support of cutting-edge basic and clinical research related to the etiology and complications of diabetes, with the goal of rapidly translating research findings into novel strategies for the prevention, treatment and cure of diabetes and related conditions.



Meharry-Vanderbilt Alliance

Executive Director: Karen Winkfield, MD, PhD

The Meharry-Vanderbilt Alliance seeks to eliminate health disparities by developing and supporting collaborative initiatives between Meharry Medical College, Vanderbilt University Medical Center, community partners and the individuals, families and communities they serve. Executive Director Karen Winkfield, MD, PhD, leads the Alliance in expanding its community-engaged research initiatives while continuing to cultivate its existing programs. 



Vanderbilt Institute for Clinical and Translational Research (VICTR)

BioVU Program Lead Investigator: Dan Roden, MD

VICTR is dedicated to transforming the way ideas and research discoveries make their way from origin to patient care, with programs aimed at speeding translation of scientific discoveries and improving treatment and health outcomes for our patients and communities.  BioVU is Vanderbilt’s biorepository of DNA extracted from discarded blood collected during routine clinical testing and linked to de-identified medical records in the Synthetic Derivative, providing a valuable resource to Vanderbilt investigators for studies of genotype-phenotype associations.



Scientific Directors: Marcela Brissova, PhD and Diane Saunders, PhD

Pancreatlas is an online imaging resource that houses reference datasets from human pancreas samples, achieved through the generosity of organ donors and their families. The database was developed by VDRC investigators and Creative Data Solutions.



All of Us

Originally called the Precision Medicine Initiative, All of Us is an historic effort to gather data from one million or more people to accelerate research and improve health. The project aims to provide a new window into the intersection of human biology, lifestyle and the environment, and more than 270,000 study participants are registered. The program's cloud-based research platform, the Researcher Workbench, was created by a team led by VUMC working alongside the Broad Institute of MIT and Harvard and Verily Life Sciences (a subsidiary of Alphabet, Inc.). Read more here.


Discover Platform

Discover is a publication of Vanderbilt University Medical Center covering breakthroughs in medical science and patient care. In addition to online articles (including those reporting on Diabetes & Endocrinology), they also host a podcast entitled Vanderbilt Health DNA: Discoveries in Action.